Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Biochim Biophys Acta Mol Basis Dis ; 1863(9): 2192-2201, 2017 09.
Article in English | MEDLINE | ID: mdl-28624490

ABSTRACT

Hydrogen sulfide (sulfide) accumulates at high levels in brain of patients with ethylmalonic encephalopathy (EE). In the present study, we evaluated whether sulfide could disturb energy and redox homeostasis, and induce mitochondrial permeability transition (mPT) pore opening in rat brain aiming to better clarify the neuropathophysiology of EE. Sulfide decreased the activities of citrate synthase and aconitase in rat cerebral cortex mitochondria, and of creatine kinase (CK) in rat cerebral cortex, striatum and hippocampus supernatants. Glutathione prevented sulfide-induced CK activity decrease in the cerebral cortex. Sulfide also diminished mitochondrial respiration in cerebral cortex homogenates, and dissipated mitochondrial membrane potential (ΔΨm) and induced swelling in the presence of calcium in brain mitochondria. Alterations in ΔΨm and swelling caused by sulfide were prevented by the combination of ADP and cyclosporine A, and by ruthenium red, indicating the involvement of mPT in these effects. Furthermore, sulfide increased the levels of malondialdehyde in cerebral cortex supernatants, which was prevented by resveratrol and attenuated by glutathione, and of thiol groups in a medium devoid of brain samples. Finally, we verified that sulfide did not alter cell viability and DCFH oxidation in cerebral cortex slices, primary cortical astrocyte cultures and SH-SY5Y cells. Our data provide evidence that bioenergetics disturbance and lipid peroxidation along with mPT pore opening are involved in the pathophysiology of brain damage observed in EE.


Subject(s)
Brain Diseases, Metabolic, Inborn/metabolism , Cerebral Cortex/metabolism , Energy Metabolism/drug effects , Hydrogen Sulfide/adverse effects , Lipid Peroxidation/drug effects , Mitochondrial Membrane Transport Proteins/metabolism , Purpura/metabolism , Animals , Brain Diseases, Metabolic, Inborn/chemically induced , Brain Diseases, Metabolic, Inborn/pathology , Cell Line, Tumor , Cerebral Cortex/pathology , Hydrogen Sulfide/pharmacology , Male , Membrane Potential, Mitochondrial/drug effects , Mitochondrial Permeability Transition Pore , Purpura/chemically induced , Purpura/pathology , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL